FDA Webview
X
Search
Log In
Home
About Us
Today@FDA
Pay Per View
Free Trial
Contact Us
More
▼
Tell Friend
Subscribe
Articles
Home /Articles / FDA Federal Register Notices
No article fund in this category
Categories
Animal Drugs
Biologics
FDA General
Federal Register
Human Drugs
Marketing
Medical Devices
Top News
Patient Injured in Intellias Phase 3 nex-z Trial Dies
FDA 483 Cites Quality Deficiencies at Indian Drug Plant
FDA Posts Biohaven Troriluzole Complete Response Letter
FDA Extends Review of Rhythms Setmelanotide sNDA
FDA OKs Darzalex Faspro for Smoldering Multiple Myeloma
Senate Democrats Caution FDA on Mifepristone Review
Baxter Oncology FDA-483 Out
76 New or Revised Product-Specific Guidances Out
Prev
FDA Webview Free Daily e-Newsletter
Free Sign-Up